Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Regulatory News (APH)

  • This share is currently suspended. It was suspended at a price of 64.70
  • There is currently no data for APH

Form 8.5 (EPT/RI)-Alliance Pharma plc

13 Jan 2025 09:02

Form 8.5 (EPT/RI)-Alliance Pharma plc

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Name of exempt principal trader:Investec Bank plc
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeAlliance Pharma plc
(c) Name of the party to the offer with which exempt principal trader is connected:Investec is financial advisor to Aegros Bidco Limited (a newly incorporated company indirectly owned by DBAY Affiliates and the ERES IV Fund)
(d) Date dealing undertaken:10th January 2024
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A”N/A

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid/receivedLowest price per unit paid/received
Ordinary sharesPurchases3,631,97261.260.8
Ordinary sharesSales3,679,32061.361

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/AN/AN/AN/AN/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
N/AN/AN/AN/AN/AN/AN/AN/A

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/AN/AN/AN/AN/A

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
N/AN/AN/AN/A

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

Date of disclosure:13th January 2025
Contact name:Priyali Bhattacharjee
Telephone number:+91 9768034903

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
1st Feb 20237:00 amRNSAppointment of NED and SID
30th Jan 20235:18 pmRNSNotification of Major Holdings
17th Jan 20237:00 amRNSFull Year Trading Update
16th Jan 20233:35 pmRNSNotification of Major Holdings
12th Jan 20237:00 amRNSSenior Management and Board Update
3rd Jan 202311:01 amRNSNotification of Major Holdings
29th Dec 202211:45 amRNSBlock Listing Six Monthly Return
22nd Dec 20229:51 amRNSNotification of Major Holdings
13th Dec 20224:58 pmRNSNotification of Major Holdings
23rd Nov 20227:00 amRNSUpdate on Q4 Trading
23rd Nov 20227:00 amRNSManagement Update
1st Nov 20225:33 pmRNSTotal Voting Rights
4th Oct 20224:48 pmRNSTotal Voting Rights
3rd Oct 20221:53 pmRNSNOTIFICATION OF MAJOR HOLDINGS
30th Sep 20224:07 pmRNSGrant of Options to Directors
20th Sep 20227:00 amRNSInterim Results
2nd Sep 20227:06 amRNSUpdate on CMA investigation
1st Sep 20225:03 pmRNSTotal Voting Rights
1st Sep 20227:00 amRNSNotification of Half Year Results
17th Aug 20221:21 pmRNSNotification of Major Holdings
17th Aug 20227:00 amRNSNotification of Major Holdings
8th Aug 20227:00 amRNSChange of Auditor
1st Aug 20226:02 pmRNSTotal Voting Rights
20th Jul 20227:00 amRNSHalf Year Trading Update
1st Jul 202210:14 amRNSTotal Voting Rights
30th Jun 202210:14 amRNSBlock Listing Six Monthly Return
17th Jun 20224:00 pmRNSBlock Admission Application
8th Jun 20227:00 amRNSTotal Voting Rights
26th May 20227:00 amRNSNotification of Major Holdings
18th May 20223:42 pmRNSResult of AGM
18th May 20227:00 amRNSDirectorate Changes
18th May 20227:00 amRNSAGM Statement
3rd May 20221:18 pmRNSTotal Voting Rights
12th Apr 202211:30 amRNSPosting of Annual Report and Notice of AGM
6th Apr 202211:12 amRNSNotification of Major Holdings
5th Apr 202210:02 amRNSAnnual Report and Notice of AGM
4th Apr 202211:17 amRNSTotal Voting Rights
25th Mar 202210:48 amRNSAcquisition to access US scar treatment market
22nd Mar 20227:00 amRNSResults for the year ended 31 December 2021
21st Mar 20221:30 pmRNSStatement regarding potential acquisition
15th Mar 20224:15 pmRNSNotification of Major Holdings
1st Mar 20223:32 pmRNSTotal Voting Rights
15th Feb 20227:00 amRNSNotification of Full Year Results
3rd Feb 20222:42 pmRNSNotification of Major Holdings
3rd Feb 20227:09 amRNSUpdate on CMA investigation
1st Feb 20224:32 pmRNSTotal Voting Rights
18th Jan 20227:30 amRNSNotification of Major Holdings
18th Jan 20227:00 amRNSFull Year Trading Update
4th Jan 20226:04 pmRNSTotal Voting Rights
29th Dec 20219:27 amRNSBlock Listing Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.